IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$1.67
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,537.7% upside
Low Target
$22.03
Average Target
$27.35
High Target
$42.34
Current Price
$1.67
Current
$1.67
$1.67
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Scenario Analysis
Bear Case
$22.03
1,219.2%
Low target
Base Case
$27.35
+1,537.7%
Avg target
Bull Case
$42.34
+2,435.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.04
-45.1% from high
52-Week Low
$0.44
+283.9% from low
Target vs 52W High
$27.35
+799.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |